We introduce the concept of the metabolic centroid spectrum as the feature space to characterize the distribution of metabolic activity in three-dimensional brains. The method computes the metabolic centroid of a brain subvolume for each increment of metabolic activity occurring in the whole brain. The result is the metabolic spectral signature, a continuous three-dimensional curve whose shape reflects the distribution of metabolic rates in the brain. The method's sensitivity to metabolic distribu tion asymmetries is greatly increased over that of the met abolic centroid method, while retaining its advantages; it is almost invariant to head size, head positioning, photon scatter, and the positron emission tomography (PET) camera's full width at half-maximum. It does not require Since the introduction of the positron emission tomography (PET) camera over 15 years ago, the scientific community has been concerned with max imizing the information that can be extracted from the PET image.
Since the introduction of the positron emission tomography (PET) camera over 15 years ago, the scientific community has been concerned with max imizing the information that can be extracted from the PET image.
The region-of-interest (ROI) method has been a major tool for this purpose. The ROls are meant to summarize the information contained in a func tional image relating some properties or patterns of the image to a functional defect, to differences among groups of subjects, or to differences in brain function before and after a stimulus.
To obtain an ROI, one or several anatomical ar- 
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magnetic resonance, computed tomography, or x-ray im ages. To test the method we analyzed the metabolic PET images of 40 normal subjects and 20 schizophrenics. The results show a unification of several metabolic character istics of schizophrenic brains, such as laterality, hy pofrontality, cortical/subcortical abnormalities, and over all brain hypometabolism, which were identified by dif ferent laboratories in separate studies using differing methodologies. Here they are presented by a single auto matic objective method. Key Words: Brain asymme tries-Cerebral glucose metabolism-Neural patterns Schizophrenia-Spectral signature-Three-dimensional pattern analysis.
ea(s) are selected a priori, and with the help of an anatomic brain atlas, computed tomography (CT), or magnetic resonance (MR) brain image, they are overlaid onto the PET functional image. With this method, once an ROI is identified, the remaining functional information of the PET image is largely disregarded; the subsequent analyses and conclu sions are based solely on comparisons of the func tional values in the selected ROI. For some re search hypotheses, such as for questions regarding a particular known pathway, this is the most appro priate protocol. However, if a pathway were not known a priori and only a few ROls were to be used, a consider able amount of meaningful information could be ne glected. Consequently, scientists have gradually in creased the number of ROls that are included in an analysis of the PET image. For example, Farkas et al. (1 984) started with two brain slices and two ROIs, Brodie et al. (1984) used one slice and 10 ROIs, Clark et al. (1985) used five slices and 53 ROIs, Buchsbaum et al. (1986) used three slices and 24 ROls, Evans et al. (1 986) used three slices and 42 ROIs, and most recently Moeller et ai. (1987) used 28 ROIs from the Evans set of ROIs.
There are some problems with this method of summarizing the information on a PET image: (a) There is a lack of agreement as to the number, size, and location of ROIs so that it is difficult to com pare results obtained by different investigators and different studies. (b) Residual errors occur in the method, produced by the overlaying of anatomic areas from a brain atlas onto a functional image, unless an additional brain size scaling process is introduced. It is difficult to estimate the magnitude of the error since the size, shape, distribution of skulls, and brain surface are highly variable from subject to subject (Dekaban and Lieberman, 1964; Fox et aI., 1985; Zhu et aI., 1986; Hatazawa et aI., 1987) . (c) When a subject's head is positioned in the PET camera, some external references, such as the canthomeatal line and laser beams, need to be em ployed to register the brain during the scan. U nfor tunately, the internal positioning of brain anatomic structures is known to vary with respect to the ex ternal skull markings from subject to subject, intro ducing additional errors in the comparisons and analyses of PET brain images (Vanier et aI., 1985) . This anatomical variability has been successfully addressed in one laboratory, which uses a Lucite plate containing seven parallel wires. By taking a lateral x-ray film of the skull, several landmarks are obtained-the wire's images and an internal bony reference-and are used to correlate the functional and anatomical brain images (Fox et aI., 1985) . (d) There are a number of instrument designs that differ in their characteristics-resolution, z-axis sam pling, sensitivity, etc.-making it very difficult to compare data from one laboratory with data from another. (e) The number of ROIs necessary to span the whole brain is much larger than the number of subjects usually available for a PET study. For this reason, statistical limitations on the significance of the findings come into play, which sometimes inval idate the study's conclusion (Ford, 1986) . If a small number of ROIs is arbitrarily selected to avoid this problem, then complex brain patterns spanning the whole brain are missed or only partially glimpsed (Schneider, 1984) .
In the present report we shall develop a method that spans the whole brain; however, since no ROIs are defined a priori, there is no need to use CT, MR, or lateral x-ray brain images as references for the PET image. Instead, an invariant coordinate refer ence system unique to each brain is obtained from the brain's geometric information contained within the PET metabolic image.
A function of interest (FOI), i.e., the brain func-tion or brain property one is interested in studying, is selected a priori. For example, one could elect to study asymmetries in metabolic activity or meta bolic differences in test-control images, etc. The in formation contained in the FOI is utilized to select a few ROIs a posteriori. This reduced number of ROls can then be studied for significance by the usual statistical methods, taking care that the crite ria for the selection of the ROIs have been specified in advance and do not bias the subsequent analysis. In contrast to the ROI method and to emphasize the difference in the flow of information, we have called this type of approach the FOI method. These meth ods are illustrated in Fig. 1 . Previous communications (L evy et al., 1987, 1989) presented the metabolic centroid method (MCM) to analyze whole three-dimensional PET brain images; the MCM does not require MR or CT scans or ROI selection and is insensitive to photon scatter, the camera's full width at half-maximum, and the positioning of the patient's head in the PET camera.
In the present report we shall expand the MCM to greatly increase its sensitivity to brain asymmetries, while preserving all its advantages. In this fashion we obtain a FOI-type method that we shall call the spectral signature method (SSM). 
THEORY
Review of the MCM In Levy et al. (1987 Levy et al. ( , 1989 we adapted the method of geometric moments to the analysis of PET met abolic images, obtaining the MCM. A brief review of the key ideas of the method includes the proper ties of the centroidal principal axes of a brain and the concept of metabolic moments.
Properties of centroidal principal axes of brain. A key idea of the MCM is to use the brain's geo metric properties, hidden in the PET metabolic im age itself, to locate the three-dimensional geometric center of the brain (x g ,Y g ,Zg) on the PET camera axis system. Then the principal axes of the brain's geo metric shape are determined with the x-axis ori ented left to right, the y-axis oriented back to front, the z-axis oriented from the brainstem to the vertex, and with the axes' origin coinciding with the geo metric center. The detailed formulas to compute the geometric center and the principal axes of the brain can be found in Levy et al. (1989) . For all 82 brains that were studied in that report, it was found that the geometric shape of each brain had distinct eigenvectors and thus the centroidal principal axes of the brain were unique to each subject. This uniqueness is to be expected in general since it is rare to find a perfectly spherical three-dimensional brain.
It was also shown that if a brain is translated or rotated when it is repositioned in the PET camera, the centroidal principal axes follow the same trans lations and rotations, becoming an ideal three dimensional coordinate reference system, since it is insensitive to head positioning within the PET cam era. The extensive numerical testing done in that report also determined that the centroidal principal axes of a PET brain image are highly insensitive to photon scatter, PET camera asymmetries, and full width at half-maximum value.
Concept of metabolic moments. The theory un derlying the use of geometric moments for pattern recognition was first proposed by Hu (1961) as a general approach to feature extraction, and it has been successfully applied by Dudani et al. (1977) for aircraft identification, Yokoyama et al. (1986) for neuron classification, and Glenn and Hatamian (1987) for character recognition.
In the geometric moments of an image, one uses as the weight function (or kernel) the nth power of the coordinates of a point in the image; however, this is only one of the many possible weighting func tions one could apply to metabolic brain images. For example, weights based on Legendre moments (Teh and Chin, 1988) or those of Zernicke moments (T eague, 198 0) are also interesting candidates. For brevity, and as a natural candidate for illustration, we shall use the geometric moments.
The computer program to implement the MCM is short and simple, and it summarizes a three dimensional metabolic brain image into four easily interpretable numbers obtained from the zeroth and the first moments of the metabolic rate images.
The mean metabolic rate per unit brain volume may may be determined by the zeroth moment for mula, and the coordinates of the metabolic centroid of the brain (x,... ,Y,... ,z,... ) may be determined using the first moment formulas with respect to the geometric center of the brain. These formulas are
where m(x,y,z) denotes the metabolic rate in the brain (mg glucose/IOO g/min), measured at the co ordinates (x,y,z) in the PET camera reference axes, V denotes the total volume of the brain, and dv = dxdydz. The total metabolic activity rate in the brain is then T,... = fvm(x,y,z)dv. If the coordinates (x ,... ,y ,... ,z ,... ) are projected onto the centroidal principal axis of the brain, it can eas ily be shown that the feature vector (may,xlJ-'y,... ,z,... ) is independent of both brain translations and rota tions (G oldstein, 198 0) .
The zeroth moment is a measure of the overall level of metabolic activity, and the first metabolic moment, the three coordinates of the metabolic centroid, are measures of the asymmetries in the metabolic image. These four parameters contained information that was sufficient to statistically differ ent a group of normal subjects from medicated chronic schizophrenics. By means of the general approach of the MCM, one can also compute the second or even higher moments of the metabolic image by modifying the exponent of the corre sponding kernel to (
adequately summarizes the information in the full metabolic image quite obviously depends on the ap plication. It would not be surprising if many param eters, higher moments, were necessary to discover complex patterns in the image data set, particularly if the subjects constituted a heterogeneous sample. For brevity, however, in the present report we shall continue to use only the low-order metabolic mo ments to describe the approach that underlies the SSM.
Metabolic SSM
Our goal is to improve the MCM's sensitivity to brain metabolic asymmetries through the introduc tion of three key concepts: the metabolic density function, the metabolic centroid function, and the spectral commonality image.
Metabolic density fu nction. The first element of the approach is the metabolic density function, which describes the distribution of metabolic activ ity levels in the brain. In the sample of 82 metabolic brain images used in Levy et al. (1989) , the meta bolic activity in a voxel ranges from ° to a maximum of �12 mg glucose utilized/ 100 g tissue/min.
Suppose that this range of metabolic activity is divided into K intervals. For example, if K = 24, then the metabolic activity can fall into one of the 24 intervals (0, 0. 5], (0.5, 1. 0], (1.0 , 1. 5], ... , (1 1 .5, 12]. Let the midrange of the kth interval be denoted by mk' k = I, ... , 24, and let us use it as an approximation to the metabolic rate of a voxel whose metabolic rate falls in the kth interval.
For a specific value of metabolic activity mk' the brain has a set of voxels, or network of subvolumes, in which the brain has a metabolic activity "approximately" equal to mk' As one lets the spe cific value of mk' k = I, ... , 24, run through the range of metabolic activity from ° to 12, different disjoint or partially contiguous subvolumes are identified whose sum is the whole brain. In the above example of 24 intervals, the whole brain is broken up in 24 such networks of subvolumes.
More generally for K intervals the metabolic ac tivity can fall into one of the intervals (O,Ll], (Ll, 2Ll] , ... , «K -1)Ll,12] where Ll = 12/K. The brain may then be considered as a sum of K disjoint net works, each one having its voxels with a metabolic activity approximately equal to mk' Denote by v m , the network of voxels of the brain whose metabolic rate is approximated by mk' Clearly there are K such "isoactivity" networks in the brain. Let Im , 
where the constant b denotes the volume of a single voxel and the sum is taken over all the voxels in the brain [in the sequel we shall drop the index k from vm " Im k ( t ), and V m , when it will cause no confusion]. Also the total metabolic activity in Vm is approx imated by mk V m' and the fraction that mk V m repre sents of the whole brain total metabolic activity rate isfm = mk V m/mav V. Letting the number of intervals K go to infinity as the volume b of a voxel ap proaches zero yields the true density functionfim), which is a continuous analogue of fm where sums are replaced by integrals. Thus, the metabolic den sity function is defined as
This function can also be interpreted as the proba bility density function of the random variable m, defined in the sample space of voxels in the three dimensional metabolic brain image.
Metabolic centroid fu nction. The second element of the approach is the metabolic centroid function. After taking the limit as K goes to infinity and the volume b of the voxel goes to zero, by analogy with Eq. I the coordinates of the metabolic centroid of the subvolume network Vm for each value mk are given by the equations f. m
where the total metabolic activity In V m IS
is to consider it as a parametric func tion representing a single curve in three-dimen sional space whose running parameter is m. Since the metabolic centroid function is computed across the whole metabolic spectrum, we have called this single curve the metabolic spectral signature (MSS).
When viewed within the methodology of pattern recognition, another interpretation of the method is to consider the MSS as the result of applying the MCM to a PET metabolic image with multiple thresholding, taking the classical "gray threshold" of pattern recognition as the metabolic activity level m (Pavlidis, 1982; Gelsema et ai., 1988) .
The increased sensitivity of the MSS method over the MCM can be easily seen if one considers that Eq. 1 can be rewritten in terms of Eqs. 3 and 4 as follows: It is important to note that a symmetric drop in metabolism in two regions on exactly opposite sides of the geometric center will be detected in the met abolic density function; however, it will not be de tected as a change in the coordinates of the meta bolic centroid.
Fortunately, within the framework of the MSS method, it is very easy to change the exponent of the kernel to, e.g., (x -xg f , (y -Yg) 2 , and (zzg f , which would detect a symmetric change; or as mentioned before, one might prefer to explore other kernel functions more suitable for the application at hand.
Spectral commonality image. This is the third and final element of the SSM. We would like to back-project the group differences and trends shown by the spectral signature onto the original PET image and detect a posteriori those ROls that are causing the group differences, taking into account the intersubject variability within the group. This can be accomplished with the concept of the spectral commonality image, a three-dimensional image Crn(x, y,z), which is constructed as follows:
Recall that the indicator function Im , (t) takes the value 1 if (mk -1:::. . 12) < t � (mk + 1:::. . 12) and 0 oth erwise; thus, Im , [m(x,y,z)] provides a binary image of the subvolumes in the network v m , ' k = 1, ... , K. Therefore, as the metabolic spectrum is swept by the value given to the parameter mk' the original PET image is unfolded into a sequence of images that we call the spectral metabolic image. For a group with N SUbjects, let their metabolic images be denoted by mn(x,Y,z), n = 1, .. . , N, and their corresponding indicator functions by ImJmn(x,y,z)]. Once the spectral metabolic images for a collection of N different subjects in a group,
.. ,K , n = 1, ... ,N, have been registered to their individual geometric cen troidal principal axes and normalized to a standard brain size (or to the particular dimensions of a brain atlas), we can compute the images
These images have voxel values ranging from c = o to c = 10 0 corresponding to an increasing com monality of the subvolumes at metabolic activity level mk• For example, if at a level mk = 5, one voxel has c = 10.0 and a second voxel has c = 95.0, this would indicate that the first voxel occurs in only 10% of the subjects in the group, while the second voxel is common to 95% of the subjects in the group. We call this image the spectral common ality image and denote it by Cm(x,y,z), (in the sequel we shall drop the subscript k).
The spectral commonality image depends only on the underlying common structure of a group of sub jects; it reflects the intersubject variability within a group. It explicitly does not depend on either the metabolic density function or on the metabolic cen troid functions of each subject, or, for that matter, on any particular FO!. For this reason it is a very useful concept since it can be applied to a host of FOIs.
For a given constant value of z, it can be used as a two-dimensional brain slice template to identify anatomical ROls that have a metabolic activity level m and are present in a group of brain images with commonality level c. This can be simply ac complished by overlaying it onto the subject's MR image or on the anatomic atlas whose dimensions were used to normalize for brain size.
The spectral commonality image can also be used to relate an a priori selected FOI to some a poste riori selected ROls that have a particular common ality level c. To this end, let us define the indicator function (7) and define the network vm.c as the set of voxels for which im,Jm,(x,y,z)] = 1. The accuracy of the elements in the commonality matrix increases as the number of subjects N in the group is increased. We speculate that the error in the estimation of each element of the commonality matrix Cm(x,y,z) should decrease in proportion to 1/(N) 1I2 , in a similar fashion as the image noise was found to decrease by intersubject averaging (Fox et aI. , 1988) .
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METHODS
Local CMRglc was measured with the PETT VI camera using the tracer [I l C]2-deoxyglucose (Reivich et aI., 1982) in a group of 40 normal subjects and a second group of 20 schizophrenics who had received no neuroleptic medica tion for at least 2 weeks before their PET scans.
The normal control group was made up of right-handed men, between the ages of 20 and 50 years, who had been selected for an absence of psychopathology. The schizo phrenic patients were also right-handed men, from 21 to 50 years of age, who satisfied the criteria for schizophre nia outlined in the Diagnostic Statistical Manual III (1980) and Research Diagnostic Criteria. Diagnostic. eval uation of each patient was performed independently by two psychiatrists. All normal subjects received a com plete physical and neurological examination to ensure that they were without medical illness. An informed con sent agreement was signed by all subjects after the nature of the procedure had been fully explained to them. The experimental design, protocols, and procedures followed the ethical principles of the Committee for the Protection of Human Subjects of New York University. The clinical profiles of these subjects have been presented in previous publications (Brodie et aI., 1985; Wolkin et aI., 1985; Volkow et ai., 1986a) .
The sensitivity of the PETT VI camera was cross calibrated with the same well counter used to measure the tracer activity in the samples of subjects' blood plasma. An attenuation correction image was generated for each subject before he received the dose of tracer. This correc tion was derived from the voxel-by-voxel ratio of the PET images collected from a gallium-68 ring with and without the subject's head in the field of view. Before administra tion of the tracer, the subject's head was positioned and fixed in the PET camera and a transmission image was measured using the same gallium-68 ring. The resulting image of attenuation coefficients was then used to correct for attenuation as well as to locate the skull edge.
Regional CMRglc values were computed from the re gional activity measures by the method of Reivich et at. (1982) . From the instant that the [I l C]2-deoxyglucose was injected, blood samples were drawn from a superficial hand vein in which arterialization had been promoted by an air circulation hand warmer. Samples were drawn suf ficiently often to represent the tracer concentrations in the blood plasma throughout the study. After the images were reconstructed and converted to represent regional CMRglc, the metabolic centroid func tion [x", (m),Y",(m), z",(m)] and the metabolic density func tion ftm) were computed for each subject in the group using Eqs. 3 and 4 and K = 24 intervals to discretize the parameter m in these parametric equations. Finally, the mean values for each group were computed as [x",(m),Y",(m),z",(m)] andftm) along with their correspond ing SEM values. The spectral commonality image was computed using Eq. 6.
RESULTS
For ease of visual interpretation, rather than plot ting the metabolic centroid function coordinates 10mg GLUl100 grlmil1
From Fig. 2 (top left) it can be seen that for the schizophrenic group the largest fraction of the brain's total metabolic activity rate TfJ.' 13%, is con tributed by the subvolume Vm whose metabolic rate m is 5.5 mg glucose/lOO g / min; while in the normal subjects only �9% of their brain's total activity oc curs at this level. The largest contribution to T fJ.'
10%, for the normal subjects occurs at a rate of 6.5 proportion of brain activity at lower metabolic rates. That is, the metabolic density of the schizo phrenics is shifted in the direction of lower meta bolic rates compared with that of the normals, in dicating a hypometabolism in schizophrenics.
From Fig. 2 (top right) it can be seen that the centroid of the subvolumes of the brains of the schizophrenics in this group, which corresponds to an activity level between 4 and 6 mg glucose/ IOO g/min, is lateralized 20° to the right side, while a smaller laterality of 5° is seen for the normal group.
In the higher metabolic range of 6 < m < 9.5, the mean spectral signature for normals has a small lat erality of 5° to the right while the schizophrenics have up to 10° laterality to the left side. This points and scaling them to the skull dimensions given by an anatomic atlas (Schaltenbrand and Wahren, 1977) . As the metabolic spectrum is scanned, Fig. 3 gives a preliminary idea of which asymmetric ROls give rise to hypofrontality and laterality since they occur more frequently across a group. At the low end of the metabolic spectrum, 1.7 < m < 3.4, the schizophrenics have hypometabolic frontal lobes with respect to the normals. In these asymmetrical neural patterns, they also have much more com monality than the normals, up to 100%, while the normals have ROIs with a low commonality that rarely reaches 50%. At the lower middle range of 3. 5 < m < 5.1, the schizophrenics have a common ality of 5�75% in much larger subcortical areas than the normals. At the upper middle range of 5.2 < m < 6.8, the schizophrenics have a commonality in the cortical areas lower than the normals.
At the high end of the metabolic spectrum, 6.9 < m < 8.5, the normals show many neural patterns still active in the cortex, while the schizophrenic frontal cortex is completely inactive at this high metabolic rate.
DISCUSSION
The purpose of this study was to develop a method for analyzing whole-b rain three-di mensional PET images that can characterize the asymmetry of the global distribution of metabolic activity in the brain, even if the pattern of neurons producing the asymmetry occupies a small percent age of the whole brain and, in addition, the location of this small neural pattern is unknown.
To achieve this goal, the MCM (Levy et ai. , points to a laterality in the schizophrenic group that was not found by the MCM.
In the past, metabolic distribution asymmetries such as laterality, hypofrontality, cortical/sub cortical abnormalities, and overall brain hypome tabolism were identified by different laboratories in separate studies by comparing the metabolic rates of preselected ROIs in PET schizophrenic brain im ages (Luchins et ai. , 1979; Buchsbaum et ai. , 1982 Buchsbaum et ai. , , 1984 Buchsbaum et ai. , , 1986 Buchsbaum et ai. , , 1987 Jernigan et ai. , 1982; Luchins, 1982; Brodie et ai. , 1984 Brodie et ai. , , 1985 Farkas et ai. , 1984; Baxter et ai. , 1985; DeLisi et ai. , 1985a,b; Wolkin et ai. , 1985; Kling et ai. , 1986; Volkow et ai. , 1986a Volkow et ai. , ,b, 1987 Buchsbaum and Haier, 1987; Gur et aI. , 1987a,b; Kishimoto et aI. , 1987) . It should be pointed out that the spectral signa tures obtained with the zeroth and first metabolic moments seem sufficient to indicate differences be tween the normal and schizophrenic data sets.
However, this does not imply that these signatures must be unique to these two groups; it is possible, albeit unlikely, that other clinical groups could have an identical signature. This potential limitation per tains to any method that compresses a popUlation's large data set to a few descriptive parameters.
Thus, the particular profiles determined by the scaled subprofile method (Moeller et ai., 1987) or the patterns extracted by the partitioning method (Clark et aI. , 1985) or the spectral signatures of the present method must establish their uniqueness, or specificity, in a comparison of the descriptive pa-rameters produced by the method when it is applied to a wide number of different clinical groups. In addition to the geometric moments, one could also apply many other types of moments to metabolic brain images. For example, the Legendre (Teh and Chin, 1988) and the Zernicke (Teague, 1980) mo ments are also interesting candidates to explore.
Perhaps they provide higher specificity than the geometric moments.
For the MSS method, the matter of uniqueness remains a subject for future research. Perhaps ad ditional descriptors, e. g. , higher moments, will be required to discover patterns in the images that are unique to a particular clinical group; on the other hand, the low-order metabolic signatures given in this report are already sufficient to establish unique ness. U sing the basic approach of the present method and a wider number of different clinical groups, we shall determine the specificity of the MSS for these and other possible modifications of the method.
Regarding the commonality matrix, surprisingly clear images of anatomical patterns seem to mate rialize from functional images; and although the neural patterns that can be seen in Fig. 3 do not appear to be caused by chance, nevertheless, the final confirmation of the neural patterns emerging from the commonality images, as well as their sta tistical, anatomical, and clinical significance, are presently the subject of intense studies.
